|This article needs additional citations for verification. (January 2011) (Learn how and when to remove this template message)|
|sulfuric acid||Mineral acid|
|Phenolsulfonic acid||Sulfonic acid|
|sulfonated phenolic compound||wood creosote|
|CAS Number||7664-93-9 1333-39-7|
|(what is this?)|
Debacterol is effective in the treatment of recurrent aphthous stomatitis (Canker Sores). Debacterol usually comes in a swab form, but is also available in a vial. Its formulation is documented more deeply in U.S. Patent 6,596,299 and U.S. Patent 6,830,757.
One clinical trial comparing Debacterol to Kenalog-in-Orabase and a no-intervention control group found that patients treated with Debacterol reported significantly better relief of symptoms compared to the other two groups 3 days after treatment. In the same study, 60% of ulcers treated with Debacterol had disappeared by day 6 compared to about 30% in the other groups.
Debacterol appears to be more effective on mouth sores in areas of the mouth which have less saliva production. Since a mouth sore must be dry prior to application of Debacterol, the area under the tongue is difficult to get a solid application on. The length of time of pain relief and the overall effectiveness may be reduced in areas such as this.
- "Debacterol product description".
- "The Miracle Canker Sore Remedy That Most Physicians Have Never Heard Of". October 2013.
- Rhodus, NL; Bereuter, J (December 1998). "An evaluation of a chemical cautery agent and an anti-inflammatory ointment for the treatment of recurrent aphthous stomatitis: a pilot study.". Quintessence international (Berlin, Germany : 1985). 29 (12): 769–73. PMID 10196853.